VNDA FDA calendar & decision history Vanda Pharmaceuticals Inc. · 1 upcoming · 3 past FDA decisions
Upcoming FDA catalysts VNDA · Dec 12, 2026 Imsidolimab FDA decision history (3) Feb 21, 2026✓ Approved FDA decision Feb 20, 2026✓ Approved Bysanti (milsaperidone) Dec 30, 2025✓ Approved FDA decision See the full 2026 PDUFA calendar → This page aggregates VNDA's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent service; "FDA", "PDUFA", and all company, drug, and ticker names are used descriptively and remain the property of their owners. Informational and educational only — not investment advice. Data and historical statistics only; no trade recommendations and no individual-drug approval probabilities. Verify every date and outcome against primary FDA / SEC / company filings. © 2026 pdufa.bio